Showing results (311-320 of 384) with videos related to
Sort By:
Pageof 39
Journal of Clinical Pathology|December 25, 2002
Detection of telomerase, its components, and human papillomavirus in cervical scrapings as a tool for triage in women with cervical dysplasiaN Reesink-Peters, M N Helder, G B A Wisman, et al.Gynecologic Oncology|February 22, 2005
Death receptors and ligands in cervical carcinogenesis: an immunohistochemical studyN Reesink-Peters, B M T Hougardy, F A J van den Heuvel, et al.Oncotarget|May 3, 2018
Proteomic alterations in early stage cervical cancerCoşkun Güzel, Natalia I Govorukhina, G Bea A Wisman, et al.International Journal of Cancer|September 4, 2009
The prognostic role of classical and nonclassical MHC class I expression in endometrial cancerClaudia B M Bijen, Enja J Bantema-Joppe, Renske A de Jong, et al.European Journal of Cancer (Oxford, England : 1990)|March 2, 2005
A phase I study of intraperitoneal topotecan in combination with intravenous carboplatin and paclitaxel in advanced ovarian cancerA M E Bos, F Y F L De Vos, E G E de Vries, et al.British Journal of Cancer|July 29, 2010
Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancerN Leffers, R S N Fehrmann, M J M Gooden, et al.Journal of Chemotherapy (Florence, Italy)|July 26, 2005
Antagonism of HSV-tk transfection and ganciclovir treatment on chemotherapeutic drug sensitivityI J Van Dillen, N H Mulder, C Meijer, et al.Clinical Epigenetics|March 11, 2016
Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3A Boers, R Wang, R W van Leeuwen, et al.Gynecologic Oncology|June 8, 2002
Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancerL S Hofstra, A M E Bos, E G E de Vries, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2003
Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinomaEleftherios P Diamandis, Andreas Scorilas, Stefano Fracchioli, et al.Pageof 39